blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1633695

EP1633695 - SMOOTH MUSCLE SPASMOLYTIC AGENTS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  21.12.2012
Database last updated on 28.09.2024
Most recent event   Tooltip18.07.2014Lapse of the patent in a contracting state
New state(s): HU
published on 20.08.2014  [2014/34]
Applicant(s)For all designated states
Bridge Pharma, Inc.
902 Contento Street
Sarasota, FL 34242 / US
[2006/11]
Inventor(s)01 / ABERG, Gunnar, A., K.
902 Contento Street
Sarasota, FL 34242 / US
02 / CHEN, Jan, L.
3 Cox Lane
Shrewsbury, MA 01545 / US
03 / MAIOLI, Andrew, T.
35 Druid Road
Warwick, RI 02888 / US
04 / WRIGHT, George, E.
298 Highland Street
Worcester, MA 01602 / US
 [2007/14]
Former [2006/11]01 / ABERG, Gunnar, A., K.
902 Contento Street
Sarasota, FL 34242 / US
02 / CHEN, Jan, L.
23 Redland Road
Shrewsbury, MA 01545 / US
03 / MAIOLI, Andrew, T.
35 Druid Road
Warwick, RI 02888 / US
04 / WRIGHT, George, E.
298 Highland Street
Worcester, MA 01602 / US
Representative(s)Gambell, Derek, et al
Graham Watt & Co LLP
St Botolph's House
7-9 St Botolph's Road
Sevenoaks
Kent TN13 3AJ / GB
[N/P]
Former [2006/11]Gambell, Derek, et al
Graham Watt & Co LLP St Botolph's House 7-9 St Botolph's Road Sevenoaks
Kent TN13 3AJ / GB
Application number, filing date04753088.621.05.2004
[2006/11]
WO2004US16199
Priority number, dateUS20030473173P23.05.2003         Original published format: US 473173 P
[2006/11]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2004105692
Date:09.12.2004
Language:EN
[2004/50]
Type: A2 Application without search report 
No.:EP1633695
Date:15.03.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 09.12.2004 takes the place of the publication of the European patent application.
[2006/11]
Type: B1 Patent specification 
No.:EP1633695
Date:15.02.2012
Language:EN
[2012/07]
Search report(s)International search report - published on:US17.03.2005
(Supplementary) European search report - dispatched on:EP14.11.2007
ClassificationIPC:C07C215/56, A61K31/137, A61P21/00
[2007/50]
CPC:
C07C215/54 (EP,US); A61P1/06 (EP); A61P1/12 (EP);
A61P1/16 (EP); A61P11/06 (EP); A61P11/08 (EP);
A61P13/02 (EP); A61P13/10 (EP); A61P13/12 (EP);
A61P15/08 (EP); A61P21/00 (EP); A61P23/02 (EP);
A61P29/00 (EP); A61P43/00 (EP); A61P7/12 (EP);
A61P9/04 (EP); A61P9/06 (EP); A61P9/10 (EP) (-)
Former IPC [2006/11]C07C211/01, A61K31/135
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/11]
TitleGerman:GLATTMUSKELSPASMOLYTIKA[2006/11]
English:SMOOTH MUSCLE SPASMOLYTIC AGENTS[2006/11]
French:AGENTS SPASMOLYTIQUES POUR MUSCLES LISSES[2006/11]
Entry into regional phase03.11.2005National basic fee paid 
03.11.2005Search fee paid 
03.11.2005Designation fee(s) paid 
03.11.2005Examination fee paid 
Examination procedure04.11.2004Request for preliminary examination filed
International Preliminary Examining Authority: US
27.10.2005Amendment by applicant (claims and/or description)
03.11.2005Examination requested  [2006/11]
29.07.2008Despatch of a communication from the examining division (Time limit: M06)
23.01.2009Reply to a communication from the examining division
02.06.2010Despatch of a communication from the examining division (Time limit: M04)
26.07.2010Reply to a communication from the examining division
05.09.2011Communication of intention to grant the patent
05.01.2012Fee for grant paid
05.01.2012Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  29.07.2008
Opposition(s)16.11.2012No opposition filed within time limit [2013/04]
Fees paidRenewal fee
19.05.2006Renewal fee patent year 03
20.04.2007Renewal fee patent year 04
24.04.2008Renewal fee patent year 05
28.05.2009Renewal fee patent year 06
29.04.2010Renewal fee patent year 07
31.05.2011Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU21.05.2004
AT15.02.2012
BE15.02.2012
CY15.02.2012
CZ15.02.2012
DK15.02.2012
EE15.02.2012
FI15.02.2012
IT15.02.2012
NL15.02.2012
PL15.02.2012
RO15.02.2012
SE15.02.2012
SI15.02.2012
SK15.02.2012
TR15.02.2012
BG15.05.2012
GR16.05.2012
IE21.05.2012
LU21.05.2012
ES26.05.2012
CH31.05.2012
LI31.05.2012
MC31.05.2012
PT15.06.2012
[2014/34]
Former [2014/27]AT15.02.2012
BE15.02.2012
CY15.02.2012
CZ15.02.2012
DK15.02.2012
EE15.02.2012
FI15.02.2012
IT15.02.2012
NL15.02.2012
PL15.02.2012
RO15.02.2012
SE15.02.2012
SI15.02.2012
SK15.02.2012
TR15.02.2012
BG15.05.2012
GR16.05.2012
IE21.05.2012
LU21.05.2012
ES26.05.2012
CH31.05.2012
LI31.05.2012
MC31.05.2012
PT15.06.2012
Former [2014/21]AT15.02.2012
BE15.02.2012
CY15.02.2012
CZ15.02.2012
DK15.02.2012
EE15.02.2012
FI15.02.2012
IT15.02.2012
NL15.02.2012
PL15.02.2012
RO15.02.2012
SE15.02.2012
SI15.02.2012
SK15.02.2012
TR15.02.2012
BG15.05.2012
GR16.05.2012
IE21.05.2012
ES26.05.2012
CH31.05.2012
LI31.05.2012
MC31.05.2012
PT15.06.2012
Former [2013/33]AT15.02.2012
BE15.02.2012
CY15.02.2012
CZ15.02.2012
DK15.02.2012
EE15.02.2012
FI15.02.2012
IT15.02.2012
NL15.02.2012
PL15.02.2012
RO15.02.2012
SE15.02.2012
SI15.02.2012
SK15.02.2012
BG15.05.2012
GR16.05.2012
IE21.05.2012
ES26.05.2012
CH31.05.2012
LI31.05.2012
MC31.05.2012
PT15.06.2012
Former [2013/22]AT15.02.2012
BE15.02.2012
CY15.02.2012
CZ15.02.2012
DK15.02.2012
EE15.02.2012
FI15.02.2012
IT15.02.2012
NL15.02.2012
PL15.02.2012
RO15.02.2012
SE15.02.2012
SI15.02.2012
SK15.02.2012
GR16.05.2012
IE21.05.2012
ES26.05.2012
CH31.05.2012
LI31.05.2012
MC31.05.2012
PT15.06.2012
Former [2013/20]AT15.02.2012
BE15.02.2012
CY15.02.2012
CZ15.02.2012
DK15.02.2012
EE15.02.2012
FI15.02.2012
IT15.02.2012
NL15.02.2012
PL15.02.2012
RO15.02.2012
SE15.02.2012
SI15.02.2012
SK15.02.2012
GR16.05.2012
IE21.05.2012
CH31.05.2012
LI31.05.2012
MC31.05.2012
PT15.06.2012
Former [2013/07]AT15.02.2012
BE15.02.2012
CY15.02.2012
CZ15.02.2012
DK15.02.2012
EE15.02.2012
FI15.02.2012
IT15.02.2012
NL15.02.2012
PL15.02.2012
RO15.02.2012
SE15.02.2012
SI15.02.2012
SK15.02.2012
GR16.05.2012
CH31.05.2012
LI31.05.2012
MC31.05.2012
PT15.06.2012
Former [2013/03]BE15.02.2012
CY15.02.2012
CZ15.02.2012
DK15.02.2012
EE15.02.2012
FI15.02.2012
IT15.02.2012
NL15.02.2012
PL15.02.2012
RO15.02.2012
SE15.02.2012
SI15.02.2012
SK15.02.2012
GR16.05.2012
MC31.05.2012
PT15.06.2012
Former [2012/50]BE15.02.2012
CY15.02.2012
CZ15.02.2012
DK15.02.2012
EE15.02.2012
FI15.02.2012
IT15.02.2012
NL15.02.2012
PL15.02.2012
RO15.02.2012
SE15.02.2012
SI15.02.2012
SK15.02.2012
GR16.05.2012
PT15.06.2012
Former [2012/49]BE15.02.2012
CY15.02.2012
CZ15.02.2012
DK15.02.2012
EE15.02.2012
FI15.02.2012
NL15.02.2012
PL15.02.2012
RO15.02.2012
SE15.02.2012
SI15.02.2012
GR16.05.2012
PT15.06.2012
Former [2012/48]BE15.02.2012
CY15.02.2012
EE15.02.2012
FI15.02.2012
NL15.02.2012
PL15.02.2012
SE15.02.2012
GR16.05.2012
PT15.06.2012
Former [2012/41]BE15.02.2012
CY15.02.2012
FI15.02.2012
NL15.02.2012
PL15.02.2012
GR16.05.2012
PT15.06.2012
Former [2012/37]BE15.02.2012
FI15.02.2012
NL15.02.2012
PL15.02.2012
GR16.05.2012
PT15.06.2012
Former [2012/36]NL15.02.2012
GR16.05.2012
Former [2012/35]NL15.02.2012
Documents cited:Search[X]US3446901  (JONES GERAINT) [X] 1 * column 3, lines 26,27 *;
 [X]GB1453394  (TAKEDA CHEMICAL INDUSTRIES LTD) [X] 1 * page 7, line 46; example 5; compound 1 * * sentence 1; example 6 * * claim 13 *;
 [X]DE2617486  (MARPHA SOC) [X] 1 * page 8, lines 7,8 *;
 [X]US4249002  (ERIKSOO EDGAR) [X] 1 * sentence 26 - sentence 27; example 7 * * sentence 30 - sentence 31; example 7 *;
 [XA]EP0325571  (KABIVITRUM AB [SE]) [X] 1 * examples 6,d),e),f),l) * * examples 18,q) * * examples 22,a); claim - * [A] 2-8;
 [A]EP0420120  (HOKURIKU PHARMACEUTICAL [JP]) [A] 1-8 * the whole document *;
 [X]WO9640097  (NPS PHARMA INC [US]) [X] 1 * compounds 67,68,72 *;
 [A]WO9800390  (BRIDGE PHARMA INC [US], et al) [A] 1-8* the whole document *;
 [DA]US6310103  (ABERG GUNNAR [US]) [DA] 1-8 * the whole document *;
 [X]  - ZHOU, XINBO ET AL, "Synthesis of 3-(2-alkoxy-5-methylphenyl)-3-phenylpropylamines", CA, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, Database accession no. 139:68991, URL: STN, XP002456786 [X] 1-5 * abstract *
 [X]  - MIYACHI H ET AL, "Novel imidazole derivatives with subtype-selective antimuscarinic activity (1)", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, OXFORD, GB, (19980721), vol. 8, no. 14, ISSN 0960-894X, pages 1807 - 1812, XP004137135 [X] 1,3-5 * page 1809; table 1; compound 1 *

DOI:   http://dx.doi.org/10.1016/S0960-894X(98)00312-6
 [X]  - EASTON, NELSON R. ET AL, "Acetylenic amines. IV", CA, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, Database accession no. 57:55898, URL: STN, XP002456787 [X] 1 * abstract *
 [X]  - BLANK, BENJAMIN ET AL, "Synthesis and adrenocortical inhibiting activity of substituted diphenylalkylamines", CA, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, Database accession no. 70:96281, URL: STN, XP002456788 [X] 1 * abstract *
 [PX]  - BALAYAN, R. S. ET AL, "Synthesis and antiarrhythmic properties of some N-substituted 3-(2-hydroxy-3,4-dimethylphenyl)-3-phenylpropylamines", CA, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, Database accession no. 143:346868, URL: STN, XP002456789 [PX] 1 * abstract *
International search[A]WO0136375  (FUJISAWA PHARMACEUTICAL CO [JP], et al)
by applicantWO9800390
 US6310103
    - ANDERSSON ET AL., J.ORG. CHEM., (1998), vol. 63, page 8067
    - NICOLAS ET AL., J. ORG. CHEM., (1993), vol. 58, page 766
 US20010775060
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.